Steven A. Cohen
Steven A. Cohen is a billionaire hedge fund investor and founder of SAC Capital Partners. He has been referred to as "A New Prince of Wall Street" by the New York Times and "The Hedge Fund King" by the Wall Street Journal. According to Forbes, he has an estimated net worth of $6.8 billion.
Cohen attended the Wharton School at the University of Pennsylvania and was hired as a junior trader at Gruntal & Co. in 1978. On his first day, he made an $8,000 profit, and eventually was making around $100,000 a day for the company.
SAC Capital Partners is a hedge fund based in Stamford, Connecticut. It was founded in 1992 by Cohen with $25 million but now currently manages $14 billion. The fund is very active accounting for about 3 percent of the NYSE's daily volume and 1 percent of the NASDAQ's daily volume. The fund's favorite industries include technology, retail/consumer goods, and healthcare.
View Older Stories View More Recent Stories
-
Cohen's SAC Discloses 5.1% Stake in Applied Bio (ABI); Wants Celera Seperated, CEO Gone and All Options Explored
-
Cohen's SAC Capital Accumulates 7.6% Stake in PF Chang's (PFCB)
-
HealthCor Discloses 5.6% Stake in Affymax (AFFY)
-
Corel (CREL) Receives Offer from Majority Shareholder for $11; SAC Capital's Steve Cohen Hired to Special Committee for Responding to Proposal
-
Cohen's SAC Capital Discloses 5% Stake in Auxilium Pharmaceuticals (AUXL)
-
Following Steven Cohen: Century Aluminum (CENX) May Be Headed to $75
-
Cohen's SAC Capital Discloses 4.1% Stake in Xenoport (XNPT)
-
Cohen's SAC Capital Moves Out of Pharmion (PHRM)
-
Following Dan Loeb: Mylan (MYL) - A Cheap Drug To Own
-
Cohen's SAC Capital Wants A Higher Bid for Pharmion (PHRM)
-
Cohen's SAC Capital Accumulates 8.3% Stake in Orexigen Therapeutics (OREX)
-
Cohen's SAC Capital Discloses 5.1% Stake in Albermarle (ALB)
-
Cohen's SAC Capital Discloses 8.9% Stake in Assured Guaranty Ltd. (AGO)
-
Cohen's SAC Capital Discloses 7.7% Stake in Takeover Target VistaCare (VSTA)
-
Cohen's SAC Capital Boosts Stake in Pharmion (PHRM) to 8.3%

